Profil

Becker Guillaume

Département des sciences cliniques

See author's contact details
Main Referenced Co-authors
Plenevaux, Alain  (53)
Bahri, Mohamed Ali  (46)
Luxen, André  (46)
Lemaire, Christian  (37)
Salmon, Eric  (26)
Main Referenced Keywords
SV2A (15); microPET (12); preclinical imaging (9); PET (8); [18F]UCB-H (7);
Main Referenced Unit & Research Centers
GIGA CRC (Cyclotron Research Center) In vivo Imaging-Aging & Memory - ULiège [BE] (39)
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège [BE] (1)
Centre de Neurosciences Cognitives et Comportementales - ULiège [BE] (1)
GIGA-CRC in vivo imaging, Nucleis (1)
GIGA-I3 - Giga-Infection, Immunity and Inflammation - ULiège [BE] (1)
Main Referenced Disciplines
Radiology, nuclear medicine & imaging (51)
Neurosciences & behavior (7)
Life sciences: Multidisciplinary, general & others (5)
Neurology (4)
Chemistry (3)

Publications (total 74)

The most downloaded
616 downloads
Bastin, C.* , Bahri, M. A.* , Meyer, F., Manard, M., Delhaye, E., Plenevaux, A., Becker, G., Seret, A., Mella, C., Giacomelli, F., Degueldre, C., Balteau, E., Luxen, A., & Salmon, E. (2020). In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H Positron Emission Tomography. European Journal of Nuclear Medicine and Molecular Imaging, 47 (2), 390-402. doi:10.1007/s00259-019-04461-x https://hdl.handle.net/2268/238877

The most cited

78 citations (Scopus®)

Bastin, C.* , Bahri, M. A.* , Meyer, F., Manard, M., Delhaye, E., Plenevaux, A., Becker, G., Seret, A., Mella, C., Giacomelli, F., Degueldre, C., Balteau, E., Luxen, A., & Salmon, E. (2020). In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H Positron Emission Tomography. European Journal of Nuclear Medicine and Molecular Imaging, 47 (2), 390-402. doi:10.1007/s00259-019-04461-x https://hdl.handle.net/2268/238877

Becker, G., Lespine, L.-F., Bahri, M. A., Serrano Navacerrada, M. E., Lemaire, C., Luxen, A., Tirelli, E., & Plenevaux, A. (2022). Exercise against cocaine sensitization in mice: a [18F]fallypride micro-PET study. Brain Communications, 4 (1), 294. doi:10.1093/braincomms/fcab294
Peer Reviewed verified by ORBi

Salmon, E., Bahri, M. A., Plenevaux, A., Becker, G., Seret, A., Delhaye, E., Degueldre, C., Balteau, E., Lemaire, C., Luxen, A., & Bastin, C. (09 August 2021). In vivo exploration of synaptic projections in frontotemporal dementia. Scientific Reports, 11, 16092. doi:10.1038/s41598-021-95499-1
Peer Reviewed verified by ORBi

Goutal, S., Guillermier, M., Becker, G., Gaudin, M., Bramoulle,, Y., Luxen, A., Lemaire, C., Plenevaux, A., SALMON, E., Hantraye, P., Barret, O., & Van Camp, N. (2021). The pharmacokinetics of [(18)F]UCB-H revisited in the healthy non-human primate brain. EJNMMI Res, 11 (1), 36. doi:10.1186/s13550-021-00777-8
Peer reviewed

Jacques, S., Arjomand, A., Perée, H., COLLINS, P., Mayer, A., Lavergne, A., Wéry, M., Mni, M., Hego, A., Thuillier, V., Becker, G., Bahri, M. A., Plenevaux, A., Di Valentin, E., Oury, C., MOUTSCHEN, M., Delvenne, P., Paquot, N., & Rahmouni, S. (2021). Dual‑specificity phosphatase 3 deletion promotes obesity, non‑alcoholic steatohepatitis and hepatocellular carcinoma. Scientific Reports, 11, 5817. doi:10.1038/s41598-021-85089-6
Peer Reviewed verified by ORBi

Becker, G., Michel, A., Bahri, M. A., Mairet-Coello, G., Lemaire, C., Deprez, T., Freyssin, A., Jacquin, L., Hustadt, F., De Wolf, C., Caruso, M., Frequin, J.-M., Gillent, E., Bezard, E., Garraux, G., Luxen, A., Citron, M., Downey, P., & Plenevaux, A. (2021). Monitoring of a progressive functional dopaminergic deficit in the A53T-AAV synuclein rats by combining 6-[ 18 F]fluoro-L-m-tyrosine imaging and motor performances analysis. Neurobiology of Aging, 107, 142-152. doi:10.1016/j.neurobiolaging.2021.07.012
Peer Reviewed verified by ORBi

Becker, G., Dammicco, S., Bahri, M. A., & SALMON, E. (14 May 2020). The Rise of Synaptic Density PET Imaging. Molecules, 25, 2303. doi:10.3390/molecules25102303
Peer Reviewed verified by ORBi

Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Seret, A., Germonpre, C., Lemaire, C., Giacomelli, F., Mievis, F., Luxen, A., Salmon, E., Rogister, B., Raedt, R., & Plenevaux, A. (2020). Exploring with [(18)F]UCB-H the in vivo Variations in SV2A Expression through the Kainic Acid Rat Model of Temporal Lobe Epilepsy. Molecular Imaging and Biology. doi:10.1007/s11307-020-01488-7
Peer Reviewed verified by ORBi

Bastin, C.* , Bahri, M. A.* , Meyer, F., Manard, M., Delhaye, E., Plenevaux, A., Becker, G., Seret, A., Mella, C., Giacomelli, F., Degueldre, C., Balteau, E., Luxen, A., & Salmon, E. (2020). In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H Positron Emission Tomography. European Journal of Nuclear Medicine and Molecular Imaging, 47 (2), 390-402. doi:10.1007/s00259-019-04461-x
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Salmon, E., Bahri, M. A., Plenevaux, A., Becker, G., Seret, A., Giacomelli, F., Delhaye, E., Degueldre, C., Balteau, E., Luxen, A., & Bastin, C. (2020). PET-[18F]UCB-H for assessing synaptic density in FTD. Alzheimer's and Dementia: the Journal of the Alzheimer's Association, 16 (S4), 037156.
Peer Reviewed verified by ORBi

Nagachinta, S., Becker, G., Dammicco, S., Serrano Navacerrada, M. E., LEROI, N., Bahri, M. A., Plenevaux, A., Lemaire, C., Lopez, R., Luxen, A., & de la Fuente, M. (2020). Radiolabelling of lipid-based nanocarriers with fluorine-18 for in vivo tracking by PET. Colloids and Surfaces B: Biointerfaces, 188, 110793. doi:10.1016/j.colsurfb.2020.110793
Peer Reviewed verified by ORBi

Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Seret, A., Mestdagh, N., Mercier, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (01 May 2019). Evaluating the In Vivo Specificity of [18F]UCB-H for the SV2A Protein, Compared with SV2B and SV2C in Rats Using microPET. Molecules, 24 (9), 1705. doi:10.3390/molecules24091705
Peer Reviewed verified by ORBi

Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Seret, A., Germonpré, C., Lemaire, C., Giacomelli, F., Mievis, F., Luxen, A., Salmon, E., Rogister, B., Raedt, R., & Plenevaux, A. (19 March 2019). Longitudinal in vivo evaluation of brain synaptic density with [18F]UCB-H through the different phases in the kainic acid rat model of temporal lobe epilepsy [Paper presentation]. 14th European Molecular Imaging Meeting, Glasgow, United Kingdom.

Manos-Turvey, A., Becker, G., Francotte, P., Serrano Navacerrada, M. E., Luxen, A., Pirotte, B., Plenevaux, A., & Lemaire, C. (11 February 2019). Fully Automated Synthesis and Evaluation of [ 18 F]BPAM121: Potential of an AMPA Receptor Positive Allosteric Modulator as PET Radiotracer. ChemMedChem, 14 (7), 788-795. doi:10.1002/cmdc.201800816
Peer Reviewed verified by ORBi

VOTTERO, G., MORFOISSE, F., Durré, T., Blacher, S., Becker, G., Bahri, M. A., Plenevaux, A., Noël, A., & NIZET, J.-L. (2019). Contralateral vascularized lymph node transfer : an optimized mouse model. Journal of Reconstructive Microsurgery Open, 4, 83-e91.
Peer reviewed

Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Seret, A., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (2019). Quantification of [18F]UCB-H Binding in the Rat Brain: From Kinetic Modelling to Standardised Uptake Value. Molecular Imaging and Biology, 21, 888-897. doi:10.1007/s11307-018-1301-0
Peer Reviewed verified by ORBi

Bastin, C., Bahri, M. A., Meyer, F., Manard, M., Delhaye, E., Plenevaux, A., Becker, G., Seret, A., Mella, C., Giacomelli, F., Degueldre, C., Balteau, E., Luxen, A., & Salmon, E. (28 November 2018). In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H Positron Emission Tomography [Paper presentation]. Belgian Molecular Imaging Community conference 'Imaging hallmarks of disease progression & treatment response', Braine-L'Alleud, Belgium.

Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Mievis, F., Giacomelli, F., Lemaire, C., Luxen, A., Salmon, E., Raedt, R., & Plenevaux, A. (18 October 2018). THE SV2A PROTEIN: IMAGING SYNAPTIC DENSITY DURING THE PROGRESSION OF THE TEMPORAL LOBE EPILEPSY IN THE KASE RAT MODEL [Poster presentation]. MINC 2018 – Multimodal Neuroimaging Cologne, Köln, Germany.

Serrano Navacerrada, M. E., Raedt, R., Becker, G., Bahri, M. A., Mievis, F., Lemaire, C., Giacomelli, F., Salmon, E., Luxen, A., & Plenevaux, A. (13 September 2018). EPILEPSY AND THE SV2A PROTEIN: new insights about the disease [Paper presentation]. 20th EURON PhD days, Brussels, Belgium.

Serrano Navacerrada, M. E., Raedt, R., Becker, G., Bahri, M. A., Mievis, F., Lemaire, C., Giacomelli, F., Salmon, E., Luxen, A., & Plenevaux, A. (13 September 2018). EPILEPSY AND THE SV2A PROTEIN: new insights about the disease [Paper presentation]. 20TH EURON PhD DAYS, Leuven, Belgium.

Bodart, G., Farhat, K., Charlet-Renard, J. D. C., Becker, G., Plenevaux, A., Salvatori, R., Geenen, V., & Martens, H. (06 June 2018). The severe deficiency of the somatotrope GHRH/GH/IGF1 axis of Ghrh-/- mice is associated with an important splenic atrophy and relative B lymphopenia. Frontiers in Endocrinology, 9 (Art. 296). doi:10.3389/fendo.2018.00296
Peer Reviewed verified by ORBi

Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Warnier, C., Mievis, F., Giacomelli, F., Lemaire, C., Luxen, A., & Plenevaux, A. (22 March 2018). [18F]UCB-H BINDING QUANTIFICATION IN RAT BRAIN: FROM MODELLING TO SUV [Poster presentation]. 13th European Molecular Imaging Meeting - EMIM 2018, San Sebastián, Spain.

Becker, G., Lespine, L.-F., Bahri, M. A., Bruneel, J., Serrano Navacerrada, M. E., Luxen, A., Tirelli, E., & Plenevaux, A. (March 2018). Increased hippocampal volume in exercising mice: comparison of control conditions with in vivo voxel based morphometry [Poster presentation]. European Molecular Imaging Meeting - EMIM 2018, San Sebastian, Spain.

Goux, M., Becker, G., Gorre, H., Dammicco, S., Desselle, A., Egrise, D., Leroi, N., LALLEMAND, F., Bahri, M. A., Doumont, G., Plenevaux, A., Cinier, M., & Luxen, A. (19 January 2018). Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of Epidermal Growth Factor Receptor Over-Expressing Tumors [Paper presentation]. 25th NKRV Workshop, Maastricht, Netherlands.

Becker, G. (2018). Presentation of the GIGA - Cyclotron Research Center [Paper presentation]. 25th NKRV Workshop.

Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (December 2017). Sv2a protein levels in the kainic acid epilepsy rat model during the acute phase. Epilepsia, 58 (Supplement S5), 1–S225.

Bahri, M. A., Plenevaux, A., Aerts, J., Bastin, C., Becker, G., Mercier, J., Valade, A., Buchanan, T., Mestdagh, N., LEDOUX, D., Seret, A., Luxen, A., & Salmon, E. (November 2017). Measuring brain synaptic vesicle protein 2A with positron emission tomography and [18F]UCB-H. Alzheimer's and Dementia: Translational Research and Clinical Interventions, 4 (4), 481-486. doi:10.1016/j.trci.2017.08.004
Peer Reviewed verified by ORBi

Goux, M., Becker, G., Gorré, H., Dammicco, S., Desselle, A., Egrise, D., Leroi, N., Lallemand, F., Bahri, M. A., Doumont, G., Plenevaux, A., Cinier, M., & Luxen, A. (21 August 2017). Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of 2 Epidermal Growth Factor Receptor Over-Expressing Tumors. Bioconjugate Chemistry, 28 (9), 2361-2371. doi:10.1021/acs.bioconjchem.7b00374
Peer Reviewed verified by ORBi

Dammicco, S., Goux, M., Lemaire, C., Becker, G., Bahri, M. A., Plenevaux, A., Cinier, M., & Luxen, A. (2017). Regiospecific radiolabelling of Nanofitin on Ni Magnetic Beads with [18F]FBEM and in vivo PET studies. Nuclear Medicine and Biology. doi:10.1016/j.nucmedbio.2017.04.006
Peer Reviewed verified by ORBi

Manos-Turvey, A., Lemaire, C., Becker, G., Plenevaux, A., Luxen, A., Pirotte, B., & Francotte, P. (August 2017). Design and Synthesis of [18F]BPAM121, a PET-Probe Targeting AMPA-subtype Glutamatergic Receptors [Poster presentation]. EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry, Vienne, Austria.

Manos-Turvey, A., Lemaire, C., Becker, G., Plenevaux, A., Luxen, A., Francotte, P., & Pirotte, B. (July 2017). Synthesis of [18F]BPAM121: An AMPAR Modulator with Potential as a PET Probe [Poster presentation]. RICT 2017, Drug Discovery and Selection, 53rd International Conference on Medicinal Chemistry, Toulouse, France.

Becker, G., Warnier, C., Serrano Navacerrada, M. E., Bahri, M. A., Mercier, J., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (26 June 2017). Pharmacokinetic characterization of [18F]UCB-H PET radiopharmaceutical in the rat brain. Molecular Pharmaceutics, 14 (8), 2719-2725. doi:10.1021/acs.molpharmaceut.7b00235
Peer Reviewed verified by ORBi

Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Garraux, G., Luxen, A., Lemaire, C., & Plenevaux, A. (10 June 2017). Evaluation of dopaminergic terminal loss in a Parkinson's disease rat model, [18F]FDOPA versus [18F]FMT microPET [Paper presentation]. SNMMI 2017 Annual Meeting, Denver, United States.

Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Garraux, G., Luxen, A., Lemaire, C., & Plenevaux, A. (May 2017). Comparative assessment of 6-[18F]fluoro-L-m-tyrosine and 6-[18F]fluoro-L-dopa to evaluate dopaminergic presynaptic integrity in a Parkinson’s disease rat model. Journal of Neurochemistry, 141, 626-635. doi:10.1111/jnc.14016
Peer Reviewed verified by ORBi

Becker, G., Lespine, L.-F., Bahri, M. A., Luxen, A., Lemaire, C., Tirelli, E., & Plenevaux, A. (05 April 2017). Functional correlates of the protective effects of free wheel-running against cocaine psychomotor sensitization on dopamine D2 receptors: a [18F]Fallypride microPET study [Paper presentation]. European Molecular Imaging Meeting - EMIM 2017, Cologne, Germany.

Becker, G., Warnier, C., Serrano Navacerrada, M. E., Bahri, M. A., Mercier, J., Luxen, A., Lemaire, C., Salmon, E., & Plenevaux, A. (19 February 2017). Noninvasive quantification of [18F]UCB-H binding using microPET and population-based input function [Poster presentation]. Neuroimaging - from Molecules to Networks - TOPIM 2017, Les Houches, France.

Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (01 February 2017). Evaluating the specificity of [18F] UCB-H for the isoform SV2A, compared with isoforms SV2B and SV2C [Poster presentation]. GIGA Day 2017, Liège, Belgium.

Salmon, E., Bahri, M. A., Manard, M., Plenevaux, A., Becker, G., Seret, A., Mella, C., Aerts, J., Giacomelli, F., Luxen, A., & Bastin, C. (2017). Decreased Synaptic Density in Early Alzheimer’s Disease Assessed with [18F]UCB-H-PET. Alzheimer's and Dementia, 13 (7), 781.
Peer reviewed

Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (2017). [18F]UCB-H RADIOTRACER AS A TOOL TO UNDERSTAND THE ROLE OF THE SV2A PROTEIN [Poster presentation]. PhD Student Day, Liège, Belgium.

Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (2017). IN VIVO STUDY OF THE SV2A PROTEIN IN AN EPILEPTIC RAT MODEL [Poster presentation]. 3rd Belgium Molecular Imaging Congress (BMIC 2017), Brussels, Belgium.

Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (2017). IN VIVO STUDY OF THE SV2A PROTEIN IN THE KAINIC ACID EPILEPSY RAT MODEL [Poster presentation]. 12th European Molecular Imaging Meeting (EMIM 2017), Cologne, Germany.

Becker, G. (2017). Preclinical imaging: a tool for translational research [Paper presentation]. GIGA Day 2017.

Becker, G., Lespine, L.-F., Serrano Navacerrada, M. E., Bahri, M. A., Luxen, A., Lemaire, C., Tirelli, E., & Plenevaux, A. (2017). Neuro-functional correlates of the protective effects of exercise against cocaine sensitization and dopamine D2 receptors density: a [18F]Fallypride microPET study [Paper presentation]. World Molecular Imaging Congress - WMIC 2017, Philadelphia, United States.

Serrano Navacerrada, M. E., Aerts, J., Bahri, M. A., Becker, G., Giacomelli, F., Lemaire, C., Luxen, A., Mercier, J., Mestdagh, N., Mievis, F., Plenevaux, A., Salmon, E., & Warnier, C. (18 November 2016). EVALUATING THE SPECIFICITY OF [18F]UCB-H FOR THE ISOFORM SV2A, COMPARED WITH ISOFORMS SV2B AND SV2C [Poster presentation]. MedChem 2016 PET & Imaging : From Chemistry Lab to Clinical Applications, Mont-Saint-Guibert, Belgium.

Bartholomé, O., Van Den Ackerveken, P., Wislet, S., Leprince, P., Rogister, B., MENTEN, C. (Other coll.), Serrano Navacerrada, M. E. (Other coll.), Neirincks, V. (Other coll.), Becker, G. (Other coll.), & Plainevaux, A. (Other coll.). (October 2016). Study of the SV2A protein role in Epilepsy [Poster presentation]. Congrès Automnal de la Belgian Society for Cell and Developmental Biology (BSCDB).

Warnier, C., Lemaire, C., Becker, G., Zaragoza, G., Giacomelli, F., Aerts, J., Otabashi, M., Bahri, M. A., Mercier, J., Plenevaux, A., & Luxen, A. (06 September 2016). Enabling efficient PET imaging of Synaptic Vesicle glycoprotein 2A (SV2A) with a robust and one-step radiosynthesis of a highly potent 18F-labelled ligand ([18F]UCB-H). Journal of Medicinal Chemistry, 59, 8955-8966. doi:10.1021/acs.jmedchem.6b00905
Peer Reviewed verified by ORBi

Gijs, M., Becker, G., Plenevaux, A., Bahri, M. A., Aerts, A., Impens, N., Baatout, S., & Luxen, A. (11 August 2016). Biodistribution of Novel 68Ga-Radiolabelled HER2 Aptamers in Mice. Journal of Nuclear Medicine and Radiation Therapy, 7 (5). doi:10.4172/2155-9619.1000300
Peer reviewed

Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Luxen, A., Garraux, G., Lemaire, C., & Plenevaux, A. (July 2016). In vivo quantification of dopaminergic terminals loss in Parkinson’s Disease rat model: comparison between [18F]FMT and [18F]FDOPA [Paper presentation]. World Molecular Imaging Congress 2015, Honolulu, United States.

Serrano Navacerrada, M. E., Becker, G., MENTEN, C., Bahri, M. A., Warnier, C., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., Rogister, B., & Plenevaux, A. (09 March 2016). EVALUATION OF SV2Alox/Cre TRANSGENIC MICE USING [18F]UCB-H IN VITRO AUTORADIOGRAPHY [Poster presentation]. European Molecular Imaging Meeting - EMIM 2016, Utrecht, Netherlands.

Becker, G., Warnier, C., Serrano Navacerrada, M. E., Bahri, M. A., Mercier, J., Luxen, A., Lemaire, C., Salmon, E., & Plenevaux, A. (08 March 2016). In vivo evaluation of [18F]UCB-H binding at SV2A protein, through a new and efficient radiosynthesis of [18F]UCB-H [Poster presentation]. European Molecular Imaging Meeting - EMIM 2016, Utrecht, Netherlands.

Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Luxen, A., Garraux, G., Lemaire, C., & Plenevaux, A. (08 March 2016). In vivo quantification of dopaminergic terminals loss in Parkinson’s Disease rat with AAV-induced overexpression of alpha-synuclein: a [18F]FMT microPET study [Poster presentation]. European Molecular Imaging Meeting - EMIM 2016, Utrecht, Netherlands.

Bodart, G., Farhat, K., RENARD, J. D. C., Becker, G., Plenevaux, A., Martens, H., Salvatori, R., & Geenen, V. (25 January 2016). Disturbed dexamethasone-induced thymus atrophy and recovery in Ghrh-/- mice with severe deficiency of the somatotrope GHRH/GH/IGF-1 axis [Paper presentation]. GIGA-Day 2016, Liège, Belgium.

Becker, G., Bolbos, R., Costes, N., Redouté, J., Newman-Tancredi, A., & Zimmer, L. (2016). Selective serotonin 5-HT1A receptor biased agonists elicit distinct brain activation patterns: a pharmacoMRI study. Scientific Reports.
Peer Reviewed verified by ORBi

Yankam Njiwa, J., Costes, N., Bouillot, C., Bouvard, S., Fieux, S., Becker, G., Levigoureux, E., Kocevar, G., Stamile, J., Langlois, J.-B., Bolbos, R., Bonnet, C., Bezin, L., Zimmer, L., & Hammers, A. (2016). Quantitative longitudinal imaging of activated microglia as a marker of inflammation in the pilocarpine rat model of epilepsy using [11C]-(R)-PK11195 PET and MRI. Journal of Cerebral Blood Flow and Metabolism.
Peer Reviewed verified by ORBi

MENTEN, C.* , Serrano Navacerrada, M. E.* , Bartholomé, O., Gil, J. S., Neirinckx, V., Wislet, S., Becker, G., Plenevaux, A., Van Den Ackerveken, P.* , & Rogister, B.*. (2016). Development and validation of a new mouse model to investigate the role of sv2a in epilepsy. PLoS ONE. doi:10.1371/journal.pone.0166525
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Serrano Navacerrada, M. E., Becker, G., MENTEN, C., Bahri, M. A., Warnier, C., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., Rogister, B., & Plenevaux, A. (04 September 2015). EVALUATION OF SV2Alox/Cre TRANSGENIC MOUSE USING [18F]UCB-H IN IN VITRO AUTORADIOGRAPHY [Poster presentation]. International Symposium "Aging and sleep: Perks for longevity?, Liège, Belgium.

Seret, A., Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Garraux, G., Luxen, A., Lemaire, C., & Plenevaux, A. (09 May 2015). [18F]FMT: a reliable PET tracer for in vivo evaluation of dopaminergic dysfunction in Parkinson’s Disease rat model [Poster presentation]. 17th Symposium of the Belgian Society of Nuclear Medicine, Maastricht, Netherlands.

Goux, M., Dammicco, S. (Other coll.), Becker, G. (Other coll.), Bahri, M. A. (Other coll.), Plenevaux, A. (Other coll.), & Luxen, A. (Other coll.). (May 2015). Strategies of regioselective radiolabeling of Nanofitin binder for imaging [Poster presentation]. BioForum 2015, Liège, Belgium.

Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Garraux, G., Lemaire, C., & Plenevaux, A. (18 March 2015). 18F-FMT: a reliable PET tracer for in vivo evaluation of dopaminergic dysfunction in Parkinson’s Disease rat model [Poster presentation]. European Molecular Imaging Meeting EMIM 2015, Tübingen, Germany.

Moës, F., Plenevaux, A., Becker, G., Tirelli, E., & Lespine, L.-F. (27 January 2015). Exploration of volumetric cerebral changes, with de micro-MRi, due to psychomotor exercise in mice [Poster presentation]. GIGA day, Liège, Belgium.

Becker, G., Streichenberger, N., Billard, T., Newman-Tancredi, A., & Zimmer, L. (2014). A Postmortem Study to Compare Agonist and Antagonist 5-HT1A Receptor-binding Sites in Alzheimer’s Disease Guillaume. CNS: Neuroscience and Therapeutics, 20.
Peer Reviewed verified by ORBi

Collomb, J., Becker, G., Fieux, S., Zimmer, L., & Billard, T. (2014). Syntheses, Radiolabelings, and in Vitro Evaluations of Fluorinated PET Radioligands of 5‑HT6 Serotoninergic Receptors. Journal of Medicinal Chemistry.
Peer Reviewed verified by ORBi

Becker, G., Collomb, J., Sgambato-Faure, V., Tremblay, L., Billard, T., & Zimmer, L. (2014). Preclinical evaluation of [18F]2FNQ1P as the first fluorinated serotonin 5-HT6 radioligand for PET imaging. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-014-2936-y
Peer Reviewed verified by ORBi

Colomb, J., Becker, G., Forcellini, E., Meyer, S., Buisson, L., Zimmer, L., & Billard, T. (2014). Synthesis and pharmacological evaluation of a new series of radiolabeled ligands for 5-HT7 receptor PET neuroimaging. Nuclear Medicine and Biology. doi:10.1016/j.nucmedbio.2014.01.008
Peer Reviewed verified by ORBi

Collomb, J., Becker, G., Zimmer, L., & Billard. (2013). Synthesis and evaluation of potential PET 18F- radioligands for the 5-HT6 receptor [Poster presentation]. 20th International Symposium on Radiopharmaceutical Sciences.

Becker, G., Streichenberger, N., Billard, T., Vacher, B., Newman-Tancredi, A., & Zimmer, L. (2013). post-mortem study to compare the 5-HT1A receptor binding of a PET agonist and a PET antagonist in Alzheimer’s disease [Paper presentation]. EANM'13 Annual Congress of the European Association of Nuclear Medicine.

Tavares, A., Becker, G., Barret, O., Morley, T., Alagille, D., Vacher, B., Newman-Tancredi, A., Tamagnan, G., & Zimmer, L. (2013). Initial evaluation of [18F]F13714, a novel 5-HT1A receptor agonist in non-human primates [Paper presentation]. EANM'13 Annual Congress of the European Association of Nuclear Medicine.

Becker, G., Collomb, J., Billard, T., & Zimmer, L. (2013). Preclinical evaluation of serotonin 5-HT6 receptor radioligands for PET imaging [Paper presentation]. EANM'13 Annual Congress of the European Association of Nuclear Medicine.

Da Costa Branquinho, E., Becker, G., Bouteiller, C., Jean, L., Renard, P.-Y., & Zimmer, L. (2013). Radiosynthesis and in vivo evaluation of fluorinated huprine derivates as PET radiotracers of acetylcholinesterase. Nuclear Medicine and Biology. doi:10.1016/j.nucmedbio.2013.02.004
Peer Reviewed verified by ORBi

Becker, G. (2013). Radiosynthesis and radiopharmacological evaluation of fluorinated PET radioligands for the 5-HT6 receptors [Poster presentation]. European Molecular Imaging Meeting.

Becker, G., Collomb, J., Billard, T., & Zimmer, L. (2013). Radiosynthesis and radiopharmacological evaluation of fluorinated PET radioligands for the 5-HT6 receptors [Paper presentation]. Society of Nuclear Medicine and Molecular Imaging Annual Meeting.

Becker, G. (2013). Towards functional TEP imaging of 5HT1A receptors [Paper presentation]. Colloque SCMC 2013.

Lemoine, L., Becker, G., Vacher, B., Billard, T., Lancelot, S., Newman-Tancredi, A., & Zimmer, L. (June 2012). Radiosynthesis and Preclinical Evaluation of 18F-F13714 as a Fluorinated 5-HT1A Receptor Agonist Radioligand for PET Neuroimaging. Journal of Nuclear Medicine, 53. doi:10.2967/jnumed.111.101212
Peer Reviewed verified by ORBi

Lemoine, L., Collomb, J., Becker, G., Liger, F., Le Bars, D., Zimmer, L., & Billard, T. (2011). 19th International Symposium on Radiopharmaceutical Sciences [Poster presentation]. Design, labelling and first radiopharmacological evaluations of novel 5HT7 receptor radioligands.

Collomb, J., Becker, G., Le Bars, D., Zimmer, L., & Billard, T. (2011). Synthesis and biological evaluation of 18F radiolabeled 5HT7 receptor ligands for medical imaging [Poster presentation]. 47th International Conference on Medicinal Chemistry.

Contact ORBi